Please login to the form below

Not currently logged in
Email:
Password:

FDA

This page shows the latest FDA news and features for those working in and with pharma, biotech and healthcare.

FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients

FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients

Antiviral drug initially scored emergency use authorisation in May. The US Food and Drug Administration (FDA) has approved Gilead’s remdesivir – now Veklury – for the treatment of hospitalised COVID-19 patients. ... In addition to the results from

Latest news

More from news
Approximately 705 fully matching, plus 2,783 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 147 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 48 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics